Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors
There is no explanation that the relevant entities of this transaction are not allowed to participate in any major asset restructuring of Listed Companies in accordance with Article 13 of the guidelines for the supervision of listed companies No. 7 – supervision of abnormal stock transactions related to major asset restructuring of listed companies Shanghai Haoyuan Chemexpress Co.Ltd(688131) (hereinafter referred to as “the company” or “the listed company”) intends to issue shares and pay cash to Wang Yuan (Wang Yuan), Shanghai Yuanmeng enterprise management consulting partnership (limited partnership), Qidong Yuanli enterprise management consulting partnership (limited partnership) and Ningbo Jiusheng innovative pharmaceutical technology Co., Ltd. acquired 100% equity of YaoYuan Pharmaceutical Chemistry (Shanghai) Co., Ltd, At the same time, it plans to issue shares to the controlling shareholders of the company to raise supporting funds (hereinafter referred to as “this transaction”).
After careful verification by the board of directors, it is hereby explained that the relevant subjects of this transaction are not allowed to participate in any major asset restructuring of Listed Companies in accordance with Article 13 of the guidelines for the supervision of listed companies No. 7 – supervision of abnormal stock transactions related to major asset restructuring of listed companies:
None of the subjects related to this transaction has been placed on file for investigation or investigation due to suspected insider trading related to this transaction, and there has been no administrative punishment by the CSRC or criminal responsibility investigated by judicial organs in accordance with the law due to insider trading related to major asset restructuring in the last 36 months.
In conclusion, the board of directors of the company believes that the relevant subjects of this transaction are not allowed to participate in any major asset restructuring of Listed Companies in accordance with Article 13 of the guidelines for the supervision of listed companies No. 7 – supervision of abnormal stock transactions related to major asset restructuring of listed companies.
It is hereby explained.
Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors March 5, 2022
